Medication adherence in adolescents with behaviorally-acquired HIV: Evidence for using a multimethod assessment protocol

Journal of Adolescent Health

Volumn 47, Issue 5, 2010, Pages 504-511

  Garvie, Patricia A ^a,b   Wilkins, Megan L ^a   Young, J Christopher ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adolescents; High risk behaviors; HIV; Medication adherence; Multimethod assessment

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; EFAVIRENZ;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CD4 LYMPHOCYTE COUNT; CLINICAL PROTOCOL; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIMETHOD STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; UNITED STATES; VIRUS LOAD;

ADOLESCENT; AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED PRACTICE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; RISK-TAKING; SOUTHEASTERN UNITED STATES; YOUNG ADULT;

EID: 78049299055     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2010.03.013     Document Type: Article

References (34)

1. T. Kerr, J. Walsh, and E. Lloyd-Smith Measuring adherence to highly active antiretroviral therapy: Implications for research and practice Curr HIV/AIDS Rep 2 2005 200 205
2. A. Cingolani, A. Antinori, and M.G. Rizzo Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: A randomized study (ARGENTA) AIDS 16 2002 369 379
3. H. Liu, L.G. Miller, and R.D. Hays Repeated measures longitudinal analyses of HIV virologic response as a function of the percent adherence, dose timing, genotypic sensitivity and other factors J Acquir Immune Defic Syndr 41 2006 315 322
4. T.C. Quinn, M.J. Wawer, and N. Sewankambo Viral load and heterosexual transmission of human immunodeficiency virus type-1 N Engl J Med 342 2000 921 929
5. M.E. Belzer, D.N. Fuchs, and G.S. Luftman Antiretroviral adherence issues among HIV-positive adolescents and young adults J Adolesc Health 25 1999 316 319
6. D.A. Murphy, C.M. Wilson, and S.J. Durako The Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA AIDS Care 13 2001 27 40
7. L. Wiener, K. Riekert, and C. Ryder Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible AIDS Patient Care STDS 18 2004 527 538
8. C.A. Mellins, E. Brackis-Cott, and C. Dolezal The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children Pediatr Infect Dis J 23 2004 1035 1041
9. S. Naar-King, G. Montepiedra, and S. Nichols Allocation of family responsibility for illness management in pediatric HIV J Pediatr Psychol 34 2009 187 194
10. P.L. Williams, D. Storm, and G. Montepiedra Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection Pediatrics 118 2006 e1745 e1757
11. S. Naar-King, M. Green, and K. Wright Ancillary services and retention of youth in HIV care AIDS Care 19 2007 248 251
12. S. Naar-King, D.A. Ellis, and A. Idalski Multisystemic therapy decreases parental overestimation of adolescent responsibility for type 1 diabetes management in urban youth Fam Syst Health 25 2007 178 189
13. J. Martinez, D. Bell, and R. Camacho Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic J Natl Med Assoc 92 2000 55 61
14. A.S. Rogers, S. Miller, and D.A. Murphy The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) Program: Theory and preliminary results J Adolesc Health 29 Suppl 1 2001 30 38
15. P.M. Flynn, B.J. Rudy, and S.D. Douglas Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy J Infect Dis 190 2004 271 279
16. P.M. Flynn, B.J. Rudy, and J.C. Lindsey Long-term observation of adolescents initiating HAART therapy: Three-year follow-up AIDS Res Hum Retroviruses 23 2007 1208 1214
17. A.M. van Rossum, P.L. Fraaij, and R. de Groot Efficacy of highly active antiretroviral therapy in HIV-1 infected children Lancet Infect Dis 2 2002 93 102
18. J.J. Farley, G. Montepiedra, and D. Storm Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count J Dev Behav Pediatr 29 2008 377 384
19. A.R. Feingold, R.M. Rutstein, and D. Meislich Protease inhibitor therapy in HIV infected children AIDS Patient Care STDS 14 2000 589 593
20. S. Martin, D.K. Elliot-DeSorbo, and P.L. Wolters Patient, caregiver, and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents Pediatr Infect Dis J 6 2007 61 67
21. Garvie PA, Cremeens J, Rai SN, et al. Comparison among adherence assessment strategies for children with perinatally acquired HIV-1: Observations from a prospective pilot study. Poster presented at: International Association of Physicians in AIDS Care/National Institute of Mental Health 1st Annual International Conference on HIV Treatment Adherence; March 2006; Jersey City, NJ.
22. J.H. Arnsten, P.A. Demas, and H. Farzadegan Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring Clin Infect Dis 33 2001 1417 1423
23. D.R. Bangsberg, F.M. Hecht, and E.D. Charlebois Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 14 2000 357 366
24. S. Naar-King, M. Frey, and M. Harris Measuring adherence to treatment of paediatric HIV/AIDS AIDS Care 17 2005 345 349
25. H. Liu, L.G. Miller, and C.E. Golin Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes Stat Med 26 2007 991 1007
26. P.T. Nieuwkerk, M.A.G. Sprangers, and D.M. Burger Limited patient adherence to highly active antiretroviral therapy for HIV-1 in an observational cohort study Arch Int Med 161 2001 1962 1968
27. SPSS Inc SPSS Base 15.0 for Windows User's Guide 2006 SPSS Inc Chicago, IL
28. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection for children less than 13 years of age MMWR Morb Mortal Wkly Rep 33 1994 1 19
29. C.R. Pearson, J.M. Simoni, and P. Hoff Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues AIDS Behav 11 2007 161 173
30. P.A. Garvie, M.L. Wilkins, and E. Kolivas Multi-method adherence assessment in youth with perinatally acquired HIV-1: The influence of off-schedule dosing in predicting biological markers Pediatr Infect Dis J 29 2010 372 374
31. N.D. Hoffman, D. Futterman, and A. Myerson Treatment issues for HIV-positive adolescents AIDS Clin Care 11 1999 17 24
32. P.T. Nieuwkerk, and F.A. Oort Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response J Acquir Immune Defic Syndr 38 2005 445 448
33. S.L. Marhefka, V.J. Tepper, and J.J. Farley Brief report: Assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview J Pediatr Psychol 31 2006 989 994
34. M. Lyon, C. Trexler, and C. Akpan-Townsend A family group approach to increasing adherence to therapy in HIV infected youth: Results of a pilot project AIDS Patient Care STDS 17 2003 299 308